Quantbot Technologies LP Takes Position in CME Group Inc. (NASDAQ:CME)

Quantbot Technologies LP purchased a new position in shares of CME Group Inc. (NASDAQ:CME) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 21,027 shares of the financial services provider’s stock, valued at approximately $4,134,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. raised its position in shares of CME Group by 1.3% during the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after purchasing an additional 48 shares during the period. Capital Advisors Ltd. LLC raised its holdings in CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after buying an additional 48 shares during the last quarter. Lantz Financial LLC raised its holdings in CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after buying an additional 49 shares during the last quarter. Lester Murray Antman dba SimplyRich lifted its stake in shares of CME Group by 0.7% in the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares in the last quarter. Finally, Greystone Financial Group LLC grew its holdings in shares of CME Group by 1.6% during the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after buying an additional 52 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.7 %

Shares of NASDAQ CME opened at $218.53 on Tuesday. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.02 and a quick ratio of 1.02. The stock has a market capitalization of $78.69 billion, a PE ratio of 24.86, a P/E/G ratio of 8.85 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $223.80. The business’s fifty day moving average price is $206.16 and its 200-day moving average price is $207.48.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating the consensus estimate of $2.53 by $0.03. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The company’s revenue was up 12.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.30 earnings per share. On average, equities research analysts anticipate that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be paid a $1.15 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.10%. CME Group’s dividend payout ratio is 52.33%.

Insider Buying and Selling at CME Group

In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.30% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft upped their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Barclays raised their target price on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a report on Thursday, July 25th. JPMorgan Chase & Co. upped their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and dropped their price objective for the company from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Finally, Piper Sandler reiterated an “overweight” rating and issued a $225.00 target price on shares of CME Group in a research note on Tuesday, August 20th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $209.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.